This timeline of Philip Morris International’s commercialisation of Iqos in the US will be updated as further developments emerge from the Food and Drug Administration’s approval process…
Though markets will be impacted by incoming regulation in 2026, TobaccoIntelligence forecasts significant growth for both heated tobacco products and nicotine pouches…
Despite inconsistent regulations and emerging taxes in 2025, nicotine pouches and heated tobacco products are expected to continue to grow steadily…
The newest edition of TobaccoIntelligence’s enforcement tracker uses data to identify trends in enforcement action, looking at how priorities in product, location and type of offence change over time…
The first nicotine pouches have successfully passed through the US Food and Drug Administration (FDA) pilot programme to streamline the premarket tobacco product applications (PMTAs) review process pouches…
US-based purveyor of age-gating technology Ispire thinks the innovation is essential to the future of all nicotine alternatives, not just vaping, though there is growing regulatory concern over the potential of nicotine pouches…
A US Supreme Court ruling against the tariffs imposed by president Donald Trump’s administration, if it happens, is unlikely to draw a line under the issue…
The legality of US tariffs on Chinese imports is now before the US Supreme Court, where initial arguments have given small hints at how the justices may rule…
A case before the US Supreme Court on whether the president has the power to implement tariffs on Chinese imports could affect prices of items like heated tobacco devices…
This timeline of tariffs will be updated as further changes are made to the US tariff policy on Chinese imports or as new documents are added to the US Federal Register…
Hysteria over vaccines in the US and changes at the Department of Health and Human Services (HHS) are introducing incoherence into all levels of public health policy to the detriment of tobacco control…
A lawsuit on the alleged violation of the ban on non-tobacco flavours for nicotine products in the California market has been settled, and the plaintiff was not the government but a rival brand…
US president Donald Trump took office amid campaign promises to cut government spending and reduce the deficit. One method his administration has used to attempt this is through reducing the federal workforce…
Heated tobacco in Japan and nicotine pouches in the US were among the success stories highlighted by Philip Morris International (PMI) in announcing its latest financial results…
A National Cancer Institute directorship prioritising cure over prevention could mean that funding for research on the impact of quitting smoking on cancer rates is likely to be limited and the first to be dropped…
The US Food and Drug Administration (FDA) issued calls for companies to voluntarily use child-resistant packaging for nicotine pouches, and for retailers to voluntarily stop selling vaping products that do not have FDA approval…
Nicotine pouches will be able to move more quickly through the US marketing authorisation process, following the launch of a pilot programme that acknowledges their place on the continuum of risk…
While the US Food and Drug Administration is embracing transparency by releasing full rejection letters for pharmaceuticals, it does not plan do the same for tobacco product denials…
The newest edition of TobaccoIntelligence’s enforcement tracker uses data to identify trends in enforcement action, looking at how priorities in product, location and type of offence are changing over time…
The appeals court held that the president lacked the constitutional authority to impose sweeping tariffs without congressional authorisation, but the tariffs remain until 14th October, allowing for a possible appeal to the Supreme Court…
The newest edition of TobaccoIntelligence’s enforcement tracker uses data to identify trends in enforcement action, looking at how priorities in product, location and type of offence are changing over time…
Enforcement against illicit alternative nicotine products on the US market has come to the fore since the Food and Drug Administration’s budget for the first time includes a minimum floor for it…
Talk of the US Office on Smoking and Health’s demise may have been premature, as its employee dismissals have been held up by lawsuits. But what would a post-OSH world look like?…
TobaccoIntelligence is introducing a new enforcement tracker that will collate online accounts of regulator action on illicit e-cigarettes and other alternative nicotine products…
China’s exclusion from the new measures, slated to take effect from 1st August, should not be interpreted as a détente, but rather as a tactical choice…
Could age-verification and age-gating technologies help get the balance right between flavoured alternative nicotine products as smoking-cessation aids for adults and keeping them away from under-age users?…
The US Supreme Court has again turned to the issue of proper venue for lawsuits, which has been brought to a head by companies challenging US Food and Drug Administration (FDA) decisions on product authorisations…
The first six months of the current administration under US president Donald Trump can be defined by its use of executive orders and imposition of tariffs on goods imported into the US…
Philip Morris International (PMI)’s modified risk tobacco product (MRTP) submission status for Zyn nicotine pouches has raised a few interesting comparisons with existing reduced-risk products…
With great fanfare, the US Food and Drug Administration has announced the rollout of its new artificial intelligence scientific review assistant, Elsa. But questions have been raised about the tool’s potential…
Last November, the feeling was that the election of US president Donald Trump indicated a general shift to the right in global politics, but the results did not quite pan out that way…
Ike Tech, co-founded by Ispire, filed the first-ever premarket tobacco product application (PMTA) with the US Food and Drug Administration (FDA) for a system that requires continuous, real-time ID verification to access ENDS devices…
New US surgeon general nominee Casey Means has not publicly laid out any position on vaping, nicotine or smoking cessation, but some of her public comments suggest she may be amenable to reduced-harm products…
Goods imported from China to the US will see a 115% reduction in tariffs as of 14th May, but the abrupt, temporary change offers no real certainty for long-term business planning…
The Tax Foundation has published a series of potential reforms it believes the US Food and Drug Administration’s Center for Tobacco Products could realistically implement to address the country’s nicotine alternatives industry…
The US nicotine pouch market is currently the world’s largest in value and number of users, and while regulation may impact its growth rates in the future, consumers continue to be attracted to the product…
The world is wondering what the real implications of US president Donald Trump’s tariffs will be on China, and whether and how the prices of affected products will dramatically increase for US consumers…
Trade relations between the US and Europe have been put on a 90-day pause, marked by a tense wait as both sides assess their next moves. Could future developments potentially involve the alternatives sector?…
The US Centers for Disease Control’s Office on Smoking and Health appears to be one of the casualties of job cuts throughout the Department of Health and Human Services…
After the White House denied the possible suspension of tariffs, the confirmation came yesterday that the president had authorised a 90-day pause for most of the countries receiving them…
As the promised axe has fallen on the workforce at the US Food and Drug Administration (FDA) Center for Tobacco Products (CTP), what comes next for the agencies and the industry?…
US president Donald Trump’s tariffs could actively harm public health – but not in a way that might be expected…
The imposition of tariffs on goods entering the US could have unintended knock-on effects elsewhere in the world, the most obvious being a general increase to prices, even in places not involved in current tariff wars…
The US Food and Drug Administration (FDA) recently highlighted the success of its Real Cost public health campaign in preventing youth e-cigarette uptake while nicotine pouch use is on the rise…
While cigarette smoking in the US has dropped to its lowest level in 60 years, overall tobacco product use among adults has remained unchanged since 2017…
Further price increases will result from the latest round of tariffs imposed by US president Donald Trump on China – though downstream impact from tariffs on North American trading partners has again been delayed…
US HSS decision-makers have been shuttling staff between employment and dismissal, much like the Grand Old Duke of York in the nursery rhyme marches troops up and down a hill…
Packaging of US nicotine alternatives could face a major shake-up, thanks to First Amendment challenges against restrictions on what companies can say and do…
Predictions on what president Donald Trump will do have always been difficult. But some indicators point to a second go-around of the Trump administration providing a degree more stability and predictability…
The nomination of Robert F Kennedy Jr., a prominent environmentalist and vaccine sceptic, as US secretary of health could have indirect implications for the nicotine alternatives industry, even in Europe…
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
